The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship "MAISKFE"

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

Evaluate the effectiveness of the of kallikrein in the different drug frequency for acute anterior circulation cerebral infarction.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 August 2016.

1 Oct 2016 10 Jun 2016 1 Dec 2018 Unavailable 1 Aug 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Parallel Assignment

Contacts